Skip to content
WeighLab

Maximus vs Claya

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Maximus

Provider comparison

People who want compounded tirzepatide at a flat price across doses and are willing to prepay at least two months, or who want brand-name pens and tablets in the same account.

Semaglutide / month
Not offered
Tirzepatide / month
$249.99/mo2-month plan, billed up front, compounded
Index 73/100 · Grade CChecked October 2026

Claya

Provider comparison

Shoppers who want one semaglutide price at any dose and will consider a multi-month prepay to get the advertised rate.

Semaglutide / month
$149/moAll doses, compounded
Tirzepatide / month
$199/moSame price regardless of dose; select multi-month plans, compounded
Index 72/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Maximus has the higher Cost-Efficiency Index: 73/100 versus 72/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Maximus
47 states
Claya
Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Maximus

Claya

Semaglutide / month
Maximus: Not offered
Claya: $149/moAll doses, compounded
Tirzepatide / month
Maximus: $249.99/mo2-month plan, billed up front, compounded
Claya: $199/moSame price regardless of dose; select multi-month plans, compounded
Semaglutide / year (modeled)
Maximus: —
Claya: $1,788
Tirzepatide / year (modeled)
Maximus: $2,988
Claya: $2,388
State availability
Maximus: 47 states
Claya: Coverage not published
Oral / sublingual option listed
Maximus: Yes
Claya: Yes
Brand-name access listed
Maximus: Yes
Claya: Yes
Provider facts checked
Maximus: October 2026
Claya: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Maximus

People who want compounded tirzepatide at a flat price across doses and are willing to prepay at least two months, or who want brand-name pens and tablets in the same account.

Reasons to consider it

  • Its pricing FAQ lists every plan length: $249.99 a month on 2 months, $219.99 on 4, $199.99 on 6 and $149.99 on 12, with no separate first-month price
  • One flat rate covers every dose tier, with no membership fee and free shipping
  • Also offers brand-name Wegovy, Ozempic, Zepbound and Mounjaro pens plus the Wegovy and Foundayo tablets

What to weigh up

  • There is no month-to-month tirzepatide plan: the shortest is two months, billed up front, and plans renew automatically at the same term
  • No compounded semaglutide option
  • No refund on medication once it has shipped, and if you aren't approved you are refunded minus the cost of the doctor consultation

Regulatory note: the FDA issued a warning letter to Maximus Health, Inc. dba Maximus in June 2026. We still list and link to Maximus; you should know the letter is on the public record before you decide.

Claya

Shoppers who want one semaglutide price at any dose and will consider a multi-month prepay to get the advertised rate.

Reasons to consider it

  • Both injections are described as the same price regardless of dosage
  • LegitScript, BBB and HIPAA badges are displayed
  • Offers brand-name Ozempic, Zepbound and Mounjaro routes alongside compounded options

What to weigh up

  • The $149/$199 rates are qualified as available with select multi-month plans; confirm the term and total before paying
  • No state coverage list is published
  • No individual prescriber or medical director is named

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

MaximusClaya
Normalized Cost/Month
Maximus:
51/100
Claya:
81/100
Price Transparency
Maximus:
94/100
Claya:
94/100
Nationwide Access
Maximus:
78/100
Claya:
24/100
Formulation Options
Maximus:
95/100
Claya:
90/100
Clinical Oversight
Maximus:
78/100
Claya:
82/100
Contract Flexibility
Maximus:
37/100
Claya:
53/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.